These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11726734)

  • 1. Fas and Fas ligand expression in maternal blood and in umbilical cord blood in preeclampsia.
    Kuntz TB; Christensen RD; Stegner J; Duff P; Koenig JM
    Pediatr Res; 2001 Dec; 50(6):743-9. PubMed ID: 11726734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):155-9. PubMed ID: 16169656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
    Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
    Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus.
    Kauma SW; Huff TF; Hayes N; Nilkaeo A
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2188-94. PubMed ID: 10372730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy.
    Karowicz-Bilińska A; Kowalska-Koprek U; Estemberg D; Sikora-Szubert A
    Ginekol Pol; 2018; 89(3):142-146. PubMed ID: 29664549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited expression of Fas and Fas ligand in fetal nucleated erythrocytes isolated from first trimester maternal blood.
    Sohda S; Samura O; Johnson KL; Falco VM; Elmes RS; Bianchi DW
    Prenat Diagn; 2002 Dec; 22(13):1213-8. PubMed ID: 12478636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
    Pongcharoen S; Searle RF; Bulmer JN
    Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and umbilical soluble Fas concentration in normotensive and preeclamptic pregnancies.
    Laskowska M; Leszczyńska-Gorzelak B; Oleszczuk J
    Int J Gynaecol Obstet; 2005 Apr; 89(1):45-6. PubMed ID: 15777898
    [No Abstract]   [Full Text] [Related]  

  • 10. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.
    Nadal C; Maurel J; Gallego R; Castells A; Longarón R; Marmol M; Sanz S; Molina R; Martin-Richard M; Gascón P
    Clin Cancer Res; 2005 Jul; 11(13):4770-4. PubMed ID: 16000573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces.
    Guller S; LaChapelle L
    Semin Reprod Endocrinol; 1999; 17(1):39-44. PubMed ID: 10406074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.
    Shimizu M; Kondo M; Ito Y; Kume H; Suzuki R; Yamaki K
    Cancer Detect Prev; 2005; 29(2):175-80. PubMed ID: 15829378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-Fas ligand system in the peripheral blood of patients with renal diseases.
    Sato M; Konuma T; Yanagisawa N; Haizuka H; Asakura H; Nakashima Y
    Nephron; 2000 Jun; 85(2):107-13. PubMed ID: 10867515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the expression of human leukocyte antigen G and preeclampsia].
    Zhao SC; Li ZB; He TQ; Yu CZ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):758-62. PubMed ID: 22321350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of soluble Fas antigen and soluble Fas ligand in mother and newborn.
    Iwama H; Akutsu H; Kuretake S; Tohma J; Nakamura N
    Arch Gynecol Obstet; 2000 Feb; 263(3):108-10. PubMed ID: 10763837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Fas antigen and soluble Fas ligand in early neonatal life.
    Sarandakou A; Protonotariou E; Rizos D; Soubassi L; Malamitsi-Puchner A
    Early Hum Dev; 2003 Dec; 75(1-2):1-7. PubMed ID: 14652155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of maternal and umbilical cord blood HIF-1α and nitric oxide levels in early and late onset preeclamptic pregnancies.
    Demircan Sezer S; Küçük M; Nergiz Avcıoğlu S; Zafer E; Altınkaya SÖ; Bıçakçı B; Yenisey Ç; Yüksel H; Kurt Ömürlü İ
    Gynecol Endocrinol; 2015; 31(12):945-8. PubMed ID: 26172929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface.
    Qiu Q; Yang M; Tsang BK; Gruslin A
    J Reprod Immunol; 2005 Apr; 65(2):121-32. PubMed ID: 15811517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of Fas antigen and ligand, placental growth factor in placenta of pregnant women with pre-eclampsia].
    Yue XY; Zhang X; Cui SH; Wang XQ
    Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):320-2. PubMed ID: 15938782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.